NIOX Group PLC

82C

Company Profile

  • Business description

    NIOX Group PLC is a medical device company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has a single operating segment: NIOX. The NIOX segment relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). Geographically, it derives a majority of its revenue from the Asia Pacific and also has a presence in the European Union, the United States, the United Kingdom, and the Rest of the world.

  • Contact

    1 Robert Robinson Avenue
    The Magdalen Centre
    The Oxford Science Park
    OxfordOX4 4GA
    GBR

    T: +44 3303309356

    E: [email protected]

    https://www.niox.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2025

    Employees

    84

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,828.7056.700.65%
CAC 407,738.4275.830.99%
DAX 4023,790.11116.820.49%
Dow JONES (US)44,484.4210.52-0.02%
FTSE 1008,774.6910.64-0.12%
HKSE24,221.41149.130.62%
NASDAQ20,393.13190.240.94%
Nikkei 22539,762.48223.85-0.56%
NZX 50 Index12,732.9551.34-0.40%
S&P 5006,227.4229.410.47%
S&P/ASX 2008,597.7056.600.66%
SSE Composite Index3,454.792.95-0.09%

Market Movers